Page last updated: 2024-11-03

procainamide and Body Weight

procainamide has been researched along with Body Weight in 6 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"Heavy male Sprague-Dawley rats die of ventricular fibrillation within 2 to 3 h after isoproterenol administration."7.67Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death. ( Balazs, T; Ehrreich, SJ; el-Hage, AN; Johnson, GL, 1986)
"Fifteen acute myocardial infarction patients (only one of whom had evidence of significant renal dysfunction) received a constant-rate intravenous infusion of procainamide at one rate for a least 24 hours."7.66Factors influencing procainamide total body clearance in the immediate postmyocardial infarction period. ( Cannon, DS; Goldreyer, BN; Lalka, D; Ludden, TM; Wyman, MG, 1981)
"Heavy male Sprague-Dawley rats die of ventricular fibrillation within 2 to 3 h after isoproterenol administration."3.67Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death. ( Balazs, T; Ehrreich, SJ; el-Hage, AN; Johnson, GL, 1986)
"Fifteen acute myocardial infarction patients (only one of whom had evidence of significant renal dysfunction) received a constant-rate intravenous infusion of procainamide at one rate for a least 24 hours."3.66Factors influencing procainamide total body clearance in the immediate postmyocardial infarction period. ( Cannon, DS; Goldreyer, BN; Lalka, D; Ludden, TM; Wyman, MG, 1981)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wyman, MG1
Goldreyer, BN1
Cannon, DS1
Ludden, TM1
Lalka, D1
Yiamouyiannis, CA1
Martin, BJ1
Watkins, JB1
Johnson, GL1
Ehrreich, SJ1
el-Hage, AN1
Balazs, T1
Dubois, EL1
Strain, L1
Shaw, TR1
Kumana, CR1
Royds, RB1
Padgham, CM1
Hamer, J1
Ruosteenoja, R1
Torsti, P1
Sothmann, A1

Trials

1 trial available for procainamide and Body Weight

ArticleYear
Experiences on a sustained-release procainamide preparation.
    Current therapeutic research, clinical and experimental, 1973, Volume: 15, Issue:10

    Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Body Weight; Clinical Trials as Topic; Dela

1973

Other Studies

5 other studies available for procainamide and Body Weight

ArticleYear
Factors influencing procainamide total body clearance in the immediate postmyocardial infarction period.
    Journal of clinical pharmacology, 1981, Volume: 21, Issue:1

    Topics: Adult; Aged; Arrhythmias, Cardiac; Body Weight; Female; Heart Failure; Humans; Male; Metabolic Clear

1981
Chronic physical activity alters hepatobiliary excretory function in rats.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:1

    Topics: Aminopyrine; Animals; Antipyrine; Bile; Body Weight; Cell Membrane; Feeding Behavior; Female; Indocy

1993
Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
    Research communications in chemical pathology and pharmacology, 1986, Volume: 51, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Body Weight; Bretylium Tosylate; Death, Sudden; Disease Models, Ani

1986
Failure of procainamide to induce a systemic lupus erythematosus-like disease in animals.
    Toxicology and applied pharmacology, 1972, Volume: 21, Issue:2

    Topics: Animals; Antibodies, Antinuclear; Blood Cell Count; Blood Volume Determination; Body Weight; Criceti

1972
Use of plasma levels in evaluation of procainamide dosage.
    British heart journal, 1974, Volume: 36, Issue:3

    Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Body Weight; Cardiac Complexes, Premature;

1974